Scholars Central

Conference abstractPublished 2015

Use of “Omics” technologies for mechanistic understandings of toxicological events

Authors: Toshinori Yamamoto

RaQualia Pharma Inc., Japan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Drug toxicity observed in pre-/non-clinical animal studies sometimes leads to discontinuation of drug candidates. Understanding the phenomena or backgrounds surrounding toxicological events occurred must be a key element for attrition improvement in research and development (R&D) of new chemical entities (NCEs), often requiring mechanistic investigations to understand toxicological mechanism of actions and then to make “Go” or “No go” decisions. In the post-genomic era, a battery of “Omics” technologies was introduced and has been rapidly increasing utilization, among which is the prefix of “toxico-” added to each omics technology in toxicology field. Especially, metabolomics in toxicology, which is so-called “toxicometabolomics”, has been widely implemented in this area. The objectives are to identify and characterize the metabolites, both endogenous and exogenous, which are the end products of cellular metabolism and drug metabolism, respectively. Moreover, toxicometabolomics enables to capture the phenotypic changes in the events, which are generated by enzymatic proteins as resultants of gene expression, at the molecular level; therefore, smooth translation of the findings can be made into the clinic. The presentation in this session will review the usefulness of toxicometabolomics technologies which are generally nuclear magnetic resonance (NMR)-based and mass spectrometry (MS)- based, and other toxic-Omics technologies. Furthermore, today, newly introduced technology, MS imaging (MSI) is considered applicable in the toxicology field, hence its toxicological usability will be also reviewed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diagnostic Techniques and Biomedical Analysis
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Toshinori Yamamoto”